{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:33:58Z","timestamp":1769758438787,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,8]]},"DOI":"10.7759\/cureus.35915","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T05:29:56Z","timestamp":1678339796000},"source":"Crossref","is-referenced-by-count":2,"title":["The First-Reported Case of Drug-Induced Hemolytic Anemia by Piperacillin-Tazobactam in a Premature Neonate: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Hamza","family":"Salim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basel","family":"Musmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fajr M","family":"A Sarhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narmeen","family":"Giacaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shatha","family":"Abu Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2006.04.001","article-title":"Kernicterus in late preterm infants cared for as term healthy infants","volume":"30","author":"Bhutani VK","year":"2006","unstructured":"Bhutani VK, Johnson L. Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol. 2006, 30:89-97. 10.1053\/j.semperi.2006.04.001","journal-title":"Semin Perinatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2021.33.4.384","article-title":"Drug-induced immune hemolytic anemia caused by postoperative cefotetan administration","volume":"33","author":"Park S","year":"2021","unstructured":"Park S, Song S, Baek J, Park H. Drug-induced immune hemolytic anemia caused by postoperative cefotetan administration. Ann Dermatol. 2021, 33:384-6. 10.5021\/ad.2021.33.4.384","journal-title":"Ann Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000440673","article-title":"Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre","volume":"42","author":"Mayer B","year":"2015","unstructured":"Mayer B, Bartolm\u00e4s T, Y\u00fcrek S, Salama A. Variability of findings in drug-induced immune haemolytic anaemia: experience over 20 years in a single centre. Transfus Med Hemother. 2015, 42:333-9. 10.1159\/000440673","journal-title":"Transfus Med Hemother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.1256","article-title":"Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient","volume":"5","author":"Kerkhoff AD","year":"2017","unstructured":"Kerkhoff AD, Patrick L, Cornett P, Kleinhenz ME, Brondfield S. Severe piperacillin-tazobactam-induced hemolysis in a cystic fibrosis patient. Clin Case Rep. 2017, 5:2059-61. 10.1002\/ccr3.1256","journal-title":"Clin Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-007801","article-title":"Unexpected outcome (positive or negative) including adverse drug reactions: life-threatening piperacillin-induced immune haemolysis in a patient with cystic fibrosis","volume":"2013","author":"Marik PE","year":"2013","unstructured":"Marik PE, Parekh P. Unexpected outcome (positive or negative) including adverse drug reactions: life-threatening piperacillin-induced immune haemolysis in a patient with cystic fibrosis. BMJ Case Rep. 2013, 2013:bcr2012007801. 10.1136\/bcr-2012-007801","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15591","article-title":"Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study","volume":"59","author":"Roehmel J","year":"2019","unstructured":"Roehmel J, Specht P, Staab D, Schwarz C, Salama A, Mayer B. Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study. Transfusion. 2019, 59:3746-54. 10.1111\/trf.15591","journal-title":"Transfusion"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-216937","article-title":"Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis","volume":"2016","author":"Meinus C","year":"2016","unstructured":"Meinus C, Schwarz C, Mayer B, Roehmel JF. Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis. BMJ Case Rep. 2016, 2016:bcr2016216937. 10.1136\/bcr-2016-216937","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2021.103324","article-title":"Pancytopenia in a newborn due to maternal piperacillin and human leukocyte antigen antibodies","volume":"61","author":"Li P","year":"2022","unstructured":"Li P, Chen Z, Wang R, et al.. Pancytopenia in a newborn due to maternal piperacillin and human leukocyte antigen antibodies. Transfus Apher Sci. 2022, 61:103324. 10.1016\/j.transci.2021.103324","journal-title":"Transfus Apher Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2010.06.004","article-title":"Immune hemolytic anemia associated with drug therapy","volume":"24","author":"Garratty G","year":"2010","unstructured":"Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev. 2010, 24:143-50. 10.1016\/j.blre.2010.06.004","journal-title":"Blood Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/161454","article-title":"Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis","volume":"2010","author":"Bandara M","year":"2010","unstructured":"Bandara M, Seder DB, Garratty G, Leger RM, Zuckerman JB. Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis. Case Rep Med. 2010, 2010:161454. 10.1155\/2010\/161454","journal-title":"Case Rep Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.0958-7578.2004.00481.x","article-title":"Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells","volume":"14","author":"Broadberry RE","year":"2004","unstructured":"Broadberry RE, Farren TW, Bevin SV, et al.. Tazobactam-induced haemolytic anaemia, possibly caused by non-immunological adsorption of IgG onto patient's red cells. Transfus Med. 2004, 14:53-7. 10.1111\/j.0958-7578.2004.00481.x","journal-title":"Transfus Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2016.01.002","article-title":"Hemolysis in preterm neonates","volume":"43","author":"Christensen RD","year":"2016","unstructured":"Christensen RD, Yaish HM. Hemolysis in preterm neonates. Clin Perinatol. 2016, 43:233-40. 10.1016\/j.clp.2016.01.002","journal-title":"Clin Perinatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00323.x","article-title":"Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells","volume":"85","author":"Arndt PA","year":"2003","unstructured":"Arndt PA, Leger RM, Garratty G. Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells. Vox Sang. 2003, 85:53. 10.1046\/j.1423-0410.2003.00323.x","journal-title":"Vox Sang"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.942288","article-title":"Immune responses in neonates","volume":"10","author":"Basha S","year":"2014","unstructured":"Basha S, Surendran N, Pichichero M. Immune responses in neonates. Expert Rev Clin Immunol. 2014, 10:1171-84. 10.1586\/1744666X.2014.942288","journal-title":"Expert Rev Clin Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698541","article-title":"Case report: first case of cefotaxime-sulbactam-induced acute intravascular hemolysis in a newborn with ABO blood type incompatibility by the mechanism of non-immunologic protein adsorption","volume":"12","author":"Wu Y","year":"2021","unstructured":"Wu Y, Wu Y, Yang Y, Chen B, Li J, Guo G, Xiong F. Case report: first case of cefotaxime-sulbactam-induced acute intravascular hemolysis in a newborn with ABO blood type incompatibility by the mechanism of non-immunologic protein adsorption. Front Immunol. 2021, 12:698541. 10.3389\/fimmu.2021.698541","journal-title":"Front Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2015.04.007","article-title":"Hemolytic disorders causing severe neonatal hyperbilirubinemia","volume":"42","author":"Christensen RD","year":"2015","unstructured":"Christensen RD, Yaish HM. Hemolytic disorders causing severe neonatal hyperbilirubinemia. Clin Perinatol. 2015, 42:515-27. 10.1016\/j.clp.2015.04.007","journal-title":"Clin Perinatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23218","article-title":"The direct antiglobulin test: a critical step in the evaluation of hemolysis","volume":"87","author":"Zantek ND","year":"2012","unstructured":"Zantek ND, Koepsell SA, Tharp DR Jr, Cohn CS. The direct antiglobulin test: a critical step in the evaluation of hemolysis. Am J Hematol. 2012, 87:707-9. 10.1002\/ajh.23218","journal-title":"Am J Hematol"},{"key":"ref18","article-title":"Severe drug-induced immune haemolytic anaemia due to ceftazidime","volume":"12","author":"Chen F","year":"2014","unstructured":"Chen F, Zhan Z. Severe drug-induced immune haemolytic anaemia due to ceftazidime. Blood Transfus. 2014, 12:435-7.","journal-title":"Blood Transfus"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.21307\/immunohematology-2019-102","article-title":"How we investigate drug-induced immune hemolytic anemia","volume":"30","author":"Leger RM","year":"2014","unstructured":"Leger RM, Arndt PA, Garratty G. How we investigate drug-induced immune hemolytic anemia. Immunohematology. 2014, 30:85-94.","journal-title":"Immunohematology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/120390-the-first-reported-case-of-drug-induced-hemolytic-anemia-by-piperacillin-tazobactam-in-a-premature-neonate-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:40Z","timestamp":1707508480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/120390-the-first-reported-case-of-drug-induced-hemolytic-anemia-by-piperacillin-tazobactam-in-a-premature-neonate-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.35915","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,8]]}}}